Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Samjin Pharmaceuticals Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Revenue Revenue Growth	274,032	274,032	250,070	185,702	201,756	200,411
Revenue Growth	45.04%	9.58%	34.66%	-7.96%	0.67%	21.18%
Gross Profit Gross Profit Growth	117,734	117,734	117,832	108,182	121,440	120,188
Operating Income Operating Income Growth	23,184	23,184	33,911	17,318	23,907	22,080
Net Income Net Income Growth	21,894	21,894	28,404	10,638	7,062	10,477
Earnings Per Share EPS Growth	1727.82	1727.82	2308.75	817.00	542.00	792.68
EPS Growth	52.00%	-25.16%	182.59%	50.74%	-31.62%	48.74%

Revenue by Geography

Chart

Fiscal Year	FY 2022	FY 2021	FY 2012	FY 2011
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011
South Korea South Korea Growth	268,863	246,493	185,702	201,756
Overseas Overseas Growth	5,169	3,578	-	-
Total Total Growth	274,032	250,070	185,702	201,756

Cash & Debt

Chart

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Cash & Investments Cash & Investments Growth	4,663	4,663	11,711	9,918	5,118	6,980
Total Debt Total Debt Growth	87,512	87,512	54,505	43,000	41,440	41,000
Net Cash (Debt) Net Cash Growth	-82,850	-82,850	-42,795	-33,082	-36,322	-34,020
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-6538.33	-6538.33	-3478.44	-2540.61	-2787.46	-2573.83

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Operating Cash Flow Operating Cash Flow Growth	17,293	17,293	23,967	33,932	12,670	16,836
Capital Expenditures CapEx Growth	-35,354	-35,354	-72,549	-12,654	-11,352	-3,914
Free Cash Flow Free Cash Flow Growth	-18,061	-18,061	-48,581	21,278	1,318	12,921
Free Cash Flow Growth	-	-	-	1514.09%	-89.80%	-

Margins

Chart

Fiscal Year	TTM	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2022	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Gross Margin	42.96%	42.96%	47.12%	58.26%	60.19%	59.97%
Operating Margin	8.46%	8.46%	13.56%	9.32%	11.85%	11.02%
Pretax Margin	9.21%	9.21%	13.96%	8.11%	10.83%	7.81%
Profit Margin	7.99%	7.99%	11.36%	5.73%	3.50%	5.23%
FCF Margin	-6.59%	-6.59%	-19.43%	11.46%	0.65%	6.45%

Dividends

Chart

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Aug 3, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Dividend Per Share Dividend Per Share Growth	800.000	800.000	800.000	-	-	50.000
Dividend Per Share Growth	0%	0%	-	-	-	77.12%
Dividend Yield	4.51%	3.52%	3.54%	-	-	0.68%

Valuation

Chart

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Aug 3, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
PE Ratio	10.22	15.72	11.53	13.21	14.85	14.38
P/FCF Ratio	-	-	-	6.60	79.58	11.66
PS Ratio	0.79	1.26	1.31	0.76	0.52	0.75

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2013

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error